Literature DB >> 15135807

Increased Th1 activity in patients with coronary artery disease.

Juliano L Fernandes1, Ronei L Mamoni, James L Orford, Concilia Garcia, Andrew P Selwyn, Otavio R Coelho, Maria Heloisa S L Blotta.   

Abstract

BACKGROUND: Atherosclerotic lesions are mainly composed of macrophages and T lymphocytes. Specific T helper type 1 (Th1) cytokines and interferon gamma (IFN-gamma) inducible chemokines have been shown to be present in these lesions, modulating the local immunologic response. To explore whether this increase in Th1 activity could also be detected in circulating cells indicating a systemic activation, we studied the peripheral expression of Th1 cytokines and chemokines in patients with coronary artery disease and controls. METHODS AND
RESULTS: Fifty patients with coronary artery disease (25 with unstable angina and 25 with stable angina) and 10 controls were studied. Serum interleukin (IL)-12 and IFN-gamma and the expression of IFN-gamma inducible chemokines IP-10, Mig and their receptor CXCR3 in peripheral cells were analyzed. Serum IL-12 and intracellular expression of IFN-gamma were significantly elevated in patients with unstable angina. An enhanced expression of IFN-gamma chemokines IP-10, Mig and CXCR3 in patients with stable angina was also observed.
CONCLUSIONS: This study demonstrates an increased systemic inflammatory activity in patients with coronary heart disease with a predominant Th1 response, particularly in patients with unstable angina, suggesting an important role played by this polarization in plaque formation and rupture. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135807     DOI: 10.1016/j.cyto.2004.01.007

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  28 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease.

Authors:  J F Ludvigsson; U de Faire; A Ekbom; S M Montgomery
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

3.  Tumor necrosis factor (TNF)-α induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB p65 methylation.

Authors:  Daniel P Harris; Smarajit Bandyopadhyay; Tyler J Maxwell; Belinda Willard; Paul E DiCorleto
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

Review 4.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

5.  Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice.

Authors:  Tian Ma; Qi Gao; Faliang Zhu; Chun Guo; Qun Wang; Fei Gao; Lining Zhang
Journal:  Cell Mol Immunol       Date:  2013-04-01       Impact factor: 11.530

6.  Low IL-10/TNFα ratio in patients with coronary artery disease and reduced left ventricular ejection fraction with a poor prognosis after 10 years.

Authors:  Jörn F Dopheide; Pascal Knopf; Geraldine C Zeller; Markus Vosseler; Nico Abegunewardene; Thomas Münzel; Christine Espinola-Klein
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

7.  Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease.

Authors:  Juliano Lara Fernandes; Carlos Vicente Serrano; Flavia Toledo; Maria Fernanda Hunziker; Augusto Zamperini; Fabio H Teo; Romulo T Oliveira; Maria Heloisa Blotta; Maria Urbana Rondon; Carlos Eduardo Negrão
Journal:  Clin Res Cardiol       Date:  2010-09-12       Impact factor: 5.460

8.  Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome.

Authors:  Min Guo; Xiaobo Mao; Qingwei Ji; Mingjian Lang; Songnan Li; Yudong Peng; Wei Zhou; Bo Xiong; Qiutang Zeng
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 9.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

10.  Lymphocyte subset characterization in patients with early clinical presentation of coronary heart disease.

Authors:  Natale Daniele Brunetti; Carmine D'Antuono; Michele Rana; Girolamo D'Arienzo; Luisa De Gennaro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.